GlassScriptPhysician profile
Ramin Ansari
NPI 1801048285
$42,628.99
in general payments reported to CMS, 2019-2025
86 companies · $8,319 in 2025
The $8,319 reported for 2025 was more than what 88% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,071 · 2020: $2,385 · 2021: $4,716 · 2022: $3,900 · 2023: $6,322 · 2024: $13K · 2025: $8,319.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,222 · Travel and Lodging: $2,220 · Education: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,761.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,222.19 |
| Travel and Lodging | $2,220.40 |
| Education | $352.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $6,552.16 | 2019-2025 | Kisunla, Amyvid, Emgality |
| Abbvie INC. | $4,107.59 | 2019-2025 | Ubrelvy, Qulipta, Botox |
| Livanova USA, INC. | $2,266.10 | 2020-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $2,054.51 | 2019-2025 | Briviact, Fintepla, Rystiggo |
| Biogen, INC. | $1,869.37 | 2019-2025 | Tysabri, Vumerity, Tysabri |
| Teva Pharmaceuticals USA, INC. | $1,688.33 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Novartis Pharmaceuticals Corporation | $1,667.59 | 2019-2025 | |
| Emd Serono, INC. | $1,414.57 | 2019-2025 | Mavenclad, Mavenclad |
| Amgen INC. | $1,185.82 | 2019-2025 | Uplizna, Aimovig |
| Sk Life Science, INC. | $1,173.14 | 2020-2025 | Xcopri |
| Pfizer INC. | $1,041.53 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $905.05 | 2020-2021 | |
| Alexion Pharmaceuticals, INC. | $839.56 | 2019-2025 | Ultomiris, Soliris |
| Neurocrine Biosciences, INC. | $811.33 | 2019-2025 | Ingrezza, Ongentys |
| Lundbeck LLC | $810.46 | 2019-2025 | Vyepti, Rexulti |
Show all 86 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $732.40 | 2019-2025 | |
| Argenx US, INC. | $702.21 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Acadia Pharmaceuticals INC | $681.97 | 2019-2025 | Nuplazid, Daybue |
| Genzyme Corporation | $645.05 | 2019-2025 | |
| Genentech USA, INC. | $584.21 | 2019-2025 | Ocrevus, Ocrevus Zunovo, Enspryng |
| Allergan, INC. | $560.39 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $528.99 | 2021-2025 | Epidiolex |
| Kyowa Kirin, INC. | $509.12 | 2020-2025 | Nourianz |
| Celgene Corporation | $507.29 | 2022-2025 | Zeposia |
| Grifols USA, LLC | $506.12 | 2019-2025 | Gamunex-C |
| Ipsen Biopharmaceuticals, INC | $495.70 | 2019-2025 | Dysport |
| Biohaven Pharmaceutical Holding Company LTD. | $449.72 | 2022 | |
| Tg Therapeutics, INC. | $391.51 | 2023-2025 | |
| Sumitomo Pharma America, INC. | $357.95 | 2023-2024 | Aptiom |
| Tanabe Pharma America, INC. | $344.54 | 2019-2025 | Radicava |
| Merz Pharmaceuticals, LLC | $296.50 | 2023-2025 | Xeomin |
| Janssen Biotech, INC. | $288.67 | 2025 | |
| Upsher-Smith Laboratories LLC | $280.18 | 2019-2022 | |
| Csl Behring | $254.11 | 2019-2025 | Hizentra, Privigen |
| E.R. Squibb & Sons, L.L.C. | $246.33 | 2021-2024 | Zeposia |
| Acorda Therapeutics, INC | $246.33 | 2019-2024 | Inbrija |
| Avanir Pharmaceuticals, INC. | $222.48 | 2019-2022 | |
| Mallinckrodt Enterprises LLC | $220.24 | 2019 | |
| Springworks Therapeutics, INC. | $217.87 | 2025 | Ogsiveo, Gomekli |
| Sunovion Pharmaceuticals INC. | $215.65 | 2019-2022 | |
| Avion Pharmaceuticals | $214.63 | 2022-2023 | Dhivy |
| Otsuka America Pharmaceutical, INC. | $208.16 | 2023-2025 | Rexulti, Nuedexta |
| Octapharma USA, INC. | $192.35 | 2023-2025 | Octagam Immune Globulin (Human), Panzyga |
| Vanda Pharmaceuticals INC. | $168.57 | 2025 | Ponvory |
| Mdd US Operations, LLC | $161.40 | 2019-2025 | Gocovri, Xadago, Apokyn |
| Catalyst Pharmaceuticals, INC. | $153.15 | 2022-2025 | Fycompa |
| Amneal Pharmaceuticals LLC | $150.62 | 2019-2022 | |
| Neurelis, INC. | $144.21 | 2020-2025 | Valtoco |
| Takeda Pharmaceuticals U.S.A., INC. | $142.29 | 2022-2025 | Hyqvia, Gammagard |
| Astrazeneca Pharmaceuticals LP | $136.61 | 2021 | |
| Ge Healthcare | $127.19 | 2019-2025 | |
| Adamas Pharmaceuticals, INC. | $107.75 | 2021 | |
| Si-Bone, INC. | $105.21 | 2019 | |
| Axsome Therapeutics, INC. | $97.77 | 2025 | Symbravo |
| Corium, LLC | $96.27 | 2023 | Adlarity |
| Tonix Medicines, INC. | $95.96 | 2025 | Zembrace Symtouch, Tonmya |
| Ani Pharmaceuticals, INC. | $95.64 | 2024-2025 | Purified Cortrophin Gel |
| Medtronic, INC. | $95.39 | 2022-2025 | Intellis Adaptivestim |
| Aprecia Pharmaceuticals, LLC | $94.74 | 2020-2023 | Spritam |
| Globus Medical, INC. | $88.33 | 2025 | Senza |
| Horizon Therapeutics Plc | $82.30 | 2021-2023 | Uplizna |
| Akcea Therapeutics, INC. | $81.96 | 2019 | |
| Azurity Pharmaceuticals, INC. | $80.80 | 2023-2025 | Horizant, Horizant |
| Abbott Laboratories | $80.47 | 2019-2023 | Infinity |
| Greenwich Biosciences, INC. | $66.82 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $63.64 | 2019-2022 | |
| Banner Life Sciences, LLC | $60.25 | 2022-2023 | |
| Currax Pharmaceuticals LLC | $58.81 | 2020-2021 | |
| Janssen Pharmaceuticals, INC | $48.08 | 2022 | |
| Boston Scientific Corporation | $45.96 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Impel Pharmaceuticals INC. | $45.12 | 2023 | Trudhesa |
| Kedrion Biopharma, INC. | $42.98 | 2024 | Albuked, Rhogam Ultra-Filtered Plus, Koate |
| Harmony Biosciences LLC | $37.50 | 2022 | |
| Sandoz INC. | $31.55 | 2023 | |
| Alfasigma USA, INC. | $31.34 | 2021 | |
| Averitas Pharma INC. | $29.56 | 2024 | Qutenza |
| Arteriocyte Medical Systems, INC. | $26.37 | 2019 | |
| Revance Therapeutics, INC. | $25.40 | 2024 | Daxxify |
| Supernus Pharmaceuticals, INC. | $22.27 | 2020 | |
| Grt US Holding, INC. | $19.63 | 2022 | |
| Alnylam Pharmaceuticals INC. | $17.46 | 2023 | Onpattro |
| Scilex Pharmaceuticals INC. | $17.40 | 2021 | |
| Vertical Pharmaceuticals, LLC | $16.98 | 2019 | |
| Promius Pharma LLC | $16.59 | 2019 | |
| Ns Pharma, INC. | $16.13 | 2025 | Viltepso |
| Collegium Pharmaceutical, INC. | $14.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramin Ansari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.